35 results
6-K
EX-10.2
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
receive payments which may be “parachute payments.” Executive and the Company will each provide the 280G Firm access to and copies of any books, records
6-K
EX-10.3
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
provide the 280G Firm access to and copies of any books, records, and documents as may be reasonably requested by the 280G Firm, and otherwise cooperate
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
-201-689-8560 (international) and use conference ID 13743026. To access the webcast presentation, please click here.
A replay of the webcast
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
”, with respect to a Party, shall mean the possession of such Party of the ability to grant a license, sublicense, a right to access, a right to use, or other … by the Applicable Laws, reasonable access to all Product Data and results, generated or obtained by or on behalf of and Controlled by Licensee or its
6-K
EX-99.2
9x73o0mr
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
pihr vktnrzq
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
z9405bd0lqhm9
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
F-3/A
s38lxkel82
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
77pwu0w78upsja4xl6u9
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
EX-1.2
qgxo8owgy
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
u7cxenh
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
omcnk oyvtkq
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-1.1
1tqhswkocs ojc2
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
xjx4a4
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.1
trb p4v7dd32
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
424B4
oiumm abbzlsi6j2
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
9ryo104
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
EX-10.2
gx5r23nrrys5hws59ul6
12 Mar 21
Registration statement (foreign) (amended)
5:02pm